226 related articles for article (PubMed ID: 38012622)
21. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms of receptor for advanced glycation end products and risk of epithelial ovarian cancer in Chinese patients.
Zhang S; Hou X; Zi S; Wang Y; Chen L; Kong B
Cell Physiol Biochem; 2013; 31(4-5):525-31. PubMed ID: 23571222
[TBL] [Abstract][Full Text] [Related]
23. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
24. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
Bao Y; Yang B; Zhao J; Shen S; Gao J
Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
[TBL] [Abstract][Full Text] [Related]
25. nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease.
Li Y; Kang S; Qin JJ; Wang N; Zhou RM; Sun HY
Gynecol Oncol; 2012 Sep; 126(3):455-9. PubMed ID: 22683585
[TBL] [Abstract][Full Text] [Related]
26. ZYG11A Is Expressed in Epithelial Ovarian Cancer and Correlates With Low Grade Disease.
Achlaug L; Somri-Gannam L; Meisel-Sharon S; Sarfstein R; Dixit M; Yakar S; Hallak M; Laron Z; Werner H; Bruchim I
Front Endocrinol (Lausanne); 2021; 12():688104. PubMed ID: 34220714
[TBL] [Abstract][Full Text] [Related]
27. Dominant-negative pathogenic variant BRIP1 c.1045G>C is a high-risk allele for non-mucinous epithelial ovarian cancer: A case-control study.
Flaum N; van Veen EM; Smith O; Amico S; Newman WG; Crosbie EJ; Edmondson R; Smith MJ; Evans DG
Clin Genet; 2022 Jan; 101(1):48-54. PubMed ID: 34585738
[TBL] [Abstract][Full Text] [Related]
28. Genetic variation in progesterone receptor gene and ovarian cancer risk: A case control study.
Kanabekova P; Al-Awadi AM; Bauyrzhanova Z; Tahtouh T; Sarray S; Almawi WY
Gene; 2022 Apr; 820():146288. PubMed ID: 35143942
[TBL] [Abstract][Full Text] [Related]
29. [Expression of p21(WAF1) and its relationship with p53 and PCNA protein in epithelial ovarian cancer].
Yan XJ; Liang LZ; Li DC; Li JL; Zhang CQ; Yuan SH
Ai Zheng; 2004 Jan; 23(1):74-80. PubMed ID: 14720380
[TBL] [Abstract][Full Text] [Related]
30. A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.
Lu Y; Beeghly-Fadiel A; Wu L; Guo X; Li B; Schildkraut JM; Im HK; Chen YA; Permuth JB; Reid BM; Teer JK; Moysich KB; Andrulis IL; Anton-Culver H; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Benitez J; Bjorge L; Brenton J; Butzow R; Caldes T; Caligo MA; Campbell I; Chang-Claude J; Claes KBM; Couch FJ; Cramer DW; Daly MB; deFazio A; Dennis J; Diez O; Domchek SM; Dörk T; Easton DF; Eccles DM; Fasching PA; Fortner RT; Fountzilas G; Friedman E; Ganz PA; Garber J; Giles GG; Godwin AK; Goldgar DE; Goodman MT; Greene MH; Gronwald J; Hamann U; Heitz F; Hildebrandt MAT; Høgdall CK; Hollestelle A; Hulick PJ; Huntsman DG; Imyanitov EN; Isaacs C; Jakubowska A; James P; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Kwong A; Le ND; Leslie G; Lesueur F; Levine DA; Mattiello A; May T; McGuffog L; McNeish IA; Merritt MA; Modugno F; Montagna M; Neuhausen SL; Nevanlinna H; Nielsen FC; Nikitina-Zake L; Nussbaum RL; Offit K; Olah E; Olopade OI; Olson SH; Olsson H; Osorio A; Park SK; Parsons MT; Peeters PHM; Pejovic T; Peterlongo P; Phelan CM; Pujana MA; Ramus SJ; Rennert G; Risch H; Rodriguez GC; Rodríguez-Antona C; Romieu I; Rookus MA; Rossing MA; Rzepecka IK; Sandler DP; Schmutzler RK; Setiawan VW; Sharma P; Sieh W; Simard J; Singer CF; Song H; Southey MC; Spurdle AB; Sutphen R; Swerdlow AJ; Teixeira MR; Teo SH; Thomassen M; Tischkowitz M; Toland AE; Trichopoulou A; Tung N; Tworoger SS; van Rensburg EJ; Vanderstichele A; Vega A; Edwards DV; Webb PM; Weitzel JN; Wentzensen N; White E; Wolk A; Wu AH; Yannoukakos D; Zorn KK; Gayther SA; Antoniou AC; Berchuck A; Goode EL; Chenevix-Trench G; Sellers TA; Pharoah PDP; Zheng W; Long J
Cancer Res; 2018 Sep; 78(18):5419-5430. PubMed ID: 30054336
[TBL] [Abstract][Full Text] [Related]
31. A targeted genetic association study of epithelial ovarian cancer susceptibility.
Earp M; Winham SJ; Larson N; Permuth JB; Sicotte H; Chien J; Anton-Culver H; Bandera EV; Berchuck A; Cook LS; Cramer D; Doherty JA; Goodman MT; Levine DA; Monteiro AN; Ness RB; Pearce CL; Rossing MA; Tworoger SS; Wentzensen N; Bisogna M; Brinton L; Brooks-Wilson A; Carney ME; Cunningham JM; Edwards RP; Fogarty ZC; Iversen ES; Kraft P; Larson MC; Le ND; Lin HY; Lissowska J; Modugno F; Moysich KB; Olson SH; Pike MC; Poole EM; Rider DN; Terry KL; Thompson PJ; van den Berg D; Vierkant RA; Vitonis AF; Wilkens LR; Wu AH; Yang HP; Ziogas A; Phelan CM; Schildkraut JM; Chen YA; Sellers TA; Fridley BL; Goode EL
Oncotarget; 2016 Feb; 7(7):7381-9. PubMed ID: 26848776
[TBL] [Abstract][Full Text] [Related]
32. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.
Reid BM; Permuth JB; Chen YA; Teer JK; Monteiro AN; Chen Z; Tyrer J; Berchuck A; Chenevix-Trench G; Doherty JA; Goode EL; Iverson ES; Lawrenson K; Pearce CL; Pharoah PD; Phelan CM; Ramus SJ; Rossing MA; Schildkraut JM; Cheng JQ; Gayther SA; Sellers TA; ; ;
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):116-125. PubMed ID: 28035019
[TBL] [Abstract][Full Text] [Related]
33. Association of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese women.
Kang S; Wang DJ; Li WS; Wang N; Zhou RM; Sun DL; Duan YN; Li SZ; Li XF; Li Y
Int J Gynecol Cancer; 2009 May; 19(4):572-7. PubMed ID: 19509552
[TBL] [Abstract][Full Text] [Related]
34. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of PIWI proteins in human stage III epithelial ovarian cancer with lymph node metastasis.
Chen C; Liu J; Xu G
Cancer Biomark; 2013; 13(5):315-21. PubMed ID: 24440970
[TBL] [Abstract][Full Text] [Related]
36. Association between
Zhang Y; Wang Y; Huang X; Li Q; Li K; You D; Song Y; Su M; Zhou B; Wang W
Biomark Med; 2019 Apr; 13(6):445-455. PubMed ID: 30929455
[No Abstract] [Full Text] [Related]
37. A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.
Zhang N; Huo Q; Wang X; Chen X; Long L; Guan X; Jiang L; Ma T; Hu W; Yang Q
Gene; 2014 Feb; 535(2):170-6. PubMed ID: 24316488
[TBL] [Abstract][Full Text] [Related]
38. Correlation between SNPs of PIK3CA, ERBB2 3'UTR, and their interactions with environmental factors and the risk of epithelial ovarian cancer.
Chen H; Zhai Z; Xie Q; Lai Y; Chen G
J Assist Reprod Genet; 2021 Oct; 38(10):2631-2639. PubMed ID: 33834328
[TBL] [Abstract][Full Text] [Related]
39. [Association between single nucleotide polymorphisms of BARD 1 gene and susceptibility of early-onset breast cancer in Uygur women in Xinjiang].
Sun G; Wang JT; Ma BL; Geng ZL; Ren GH; Shan MH; Ma B; Ma LL; Wang Y
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):341-7. PubMed ID: 22883453
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women.
Grant DJ; Manichaikul A; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Moorman PG; Peres LC; Peters ES; Schwartz AG; Terry PD; Wang XQ; Keku TO; Hoyo C; Berchuck A; Sandler DP; Taylor JA; O'Brien KM; Velez Edwards DR; Edwards TL; Beeghly-Fadiel A; Wentzensen N; Pearce CL; Wu AH; Whittemore AS; McGuire V; Sieh W; Rothstein JH; Modugno F; Ness R; Moysich K; Rossing MA; Doherty JA; Sellers TA; Permuth-Way JB; Monteiro AN; Levine DA; Setiawan VW; Haiman CA; LeMarchand L; Wilkens LR; Karlan BY; Menon U; Ramus S; Gayther S; Gentry-Maharaj A; Terry KL; Cramer DW; Goode EL; Larson MC; Kaufmann SH; Cannioto R; Odunsi K; Etter JL; Huang RY; Bernardini MQ; Tone AA; May T; Goodman MT; Thompson PJ; Carney ME; Tworoger SS; Poole EM; Lambrechts D; Vergote I; Vanderstichele A; Van Nieuwenhuysen E; Anton-Culver H; Ziogas A; Brenton JD; Bjorge L; Salvensen HB; Kiemeney LA; Massuger LFAG; Pejovic T; Bruegl A; Moffitt M; Cook L; Le ND; Brooks-Wilson A; Kelemen LE; Pharoah PDP; Song H; Campbell I; Eccles D; DeFazio A; Kennedy CJ; Schildkraut JM
Cancer Med; 2019 May; 8(5):2503-2513. PubMed ID: 31001917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
